Evaluation of the Safety, Systemic Pharmacokinetics, and Tolerability

Completed · Phase 1

Conditions studied: Eye Pain

In brief

Evaluation of the Safety, Systemic Pharmacokinetics, and Tolerability of Single and Repeat Ocular Instillations of Loteprednol Etabonate Ophthalmic Gel, in Normal Healthy Volunteers

Key facts

Study ID

NCT03063489

Run by

Bausch Health Americas, Inc.

People needed

15

Starts

2015-02-01

Expected to finish

2015-07-01

Last updated by the study team

2017-02-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

Where it is running

• Valeant Site 01 — Phoenix, Arizona, United States
• Valeant Site 03 — Oceanside, California, United States
• Valeant Site 05 — Miami, Florida, United States
• Valeant Site 04 — Quincy, Massachusetts, United States
• Valeant Site 06 — Kansas City, Missouri, United States
• Valeant Site 02 — St Louis, Missouri, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.